Dusa acne treatment

Journal of Drugs in Dermatology, Jan, 2006

Dusa Pharmaceuticals, Inc., reported that 14/15 patients treated with Levulan followed by pulsed dye laser had complete clearance of their facial acne for a mean duration of 6.4 months. One patient dropped out of the study prior to completion. Four other patients were treated with either Levulan alone or oral antibiotics and did not experience remission.

Pipeline Previews is a feature that will appear in each issue. It will bring to you information on the newest drugs and medical products as they become available to the dermatological community. These features may include additional information from the manufacturers, plus reports from physicians who wish to share their clinical experience with these new products. In addition, we will inform our readers about the latest drugs receiving FDA approval. We trust you will find this information beneficial in your practice and research.